Latest filing published 22 Sept 2020 for Edesa Biotech, Inc. (formerly Stellar Biotechnologies, Inc.).
Pardeep Nijhawan discloses dealings in Edesa Biotech, Inc. (formerly Stellar Biotechnologies, Inc.) to SEDI. The record holds 17 filings, for trades running from 7 June 2019 to 17 September 2020.
Purchases make up the whole of the open-market record (6 purchases, €12k). Unlike grants, an open-market purchase is paid for by the insider, at the market price. In 2020 alone, the filings show 6 purchases and no sales.
A typical purchase (the median) is worth €1,213. None of the 5 purchases we analysed coincided with buying by another insider of the same company within 30 days.
The newest entry dates from 22 September 2020: a transaction, in Edesa Biotech, Inc. (formerly Stellar Biotechnologies, Inc.). The last insider purchase was made public on 28 May 2020, 2,340 days ago. The median gap between a trade and its publication by SEDI is 5 days. The shorter that gap, the sooner other investors can see what insiders have done. These figures are compiled from regulatory filings published by SEDI. They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
16 of 16 declarations